ternspharma.com (TERN) - Rasio rega marang prakiraan pendapatan

High barriers to entry and stringent FDA requirements protect Terns Pharmaceuticals (TERN) from smaller players. This expected P/S chart for the company on GURU.Markets visualizes market expectations, where the 456.60 metric determines this level. Business value growth relies on the rollout of obesity and NASH drugs, and the active acceleration of clinical trials has now reached its peak.

TERN Terns Pharma: Rasio kapitalisasi marang dodolan sing dikarepake ing interval 04.07.2022 - 01.04.2023

Rincian metrik keuangan lan pasar Terns Corp (TERN)

- rega pasar lan target rega analis:

Bagan rega Terns Pharmaceuticals, Inc.|TERN - Konsensus nilai wajar

- indikator kapitalisasi pasar:

Nilai pasar Terns Corp|TERN - Nilai Bisnis

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham Terns Pharmaceuticals|TERN - Pambiji Buku Bisnis|Rasio Kapitalisasi marang Aset Bersih ternspharma.com|TERN - Nilai Agregat Aset

- indikator total utang lan likuiditas perusahaan:

Utang marang Ekuitas Terns Pharmaceuticals|TERN - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang modal Terns Pharmaceuticals|TERN - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Terns Corp|TERN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Terns Pharmaceuticals|Likuiditas cepet ternspharma.com

- data bathi bisnis lan rasio investasi:

TERN - Penghasilan resik|Proyeksi bathi mangsa ngarep Terns Pharmaceuticals|TERN - Pangali P/E|Pangali Forward P/E Terns Pharmaceuticals Inc|TERN - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Terns Corp|TERN - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Terns Pharmaceuticals|TERN - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ternspharma.com|TERN - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Terns Pharmaceuticals

- indikator volume dodolan lan pendapatan:

TERN - Pendapatan reged perusahaan|Prakiraan volume dodolan Terns Pharmaceuticals, Inc.|TERN - Kapitalisasi marang pendapatan|Multiplikator Forward P/S Terns Corp

Ringkesan analisis perusahaan:Terns Pharmaceuticals, Inc. TERN

The prospects of Terns Pharmaceuticals (TERN) depend on the success of innovative drugs for the treatment of liver diseases. The forward price-to-sales valuation trend reflects the ratio of current market capitalization to expected sales, measuring the degree of market optimism. Sharp peaks on the chart signal that the asset is overbought and highlight risks of a deep correction. Amid intense competition with pharma behemoths, this indicator helps assess whether the premium for the company's future success is justified.

Pesaing Terns Pharmaceuticals

Rasio rega marang prakiraan pendapatan Phathom Pharmaceuticals, Inc. PHAT|Rega forward marang dodolan IRWD|CURX - Rasio rega marang prakiraan pendapatan|IMRN (Immuron Limited) - Kapitalisasi marang prakiraan pendapatan|Evoke Pharma, Inc. (EVOK) - Rasio rega marang prakiraan pendapatan|ENTO - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan RDHL|PALI: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Jaguar Animal Health (JAGX)|BIOR: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S MORF (Morphic Holding, Inc.)